Drugs (Pharmaceuticals) – Page 2

Trump Plan Would Tie Some Drug Prices to What Peer Nations Pay

The president announced an executive order aimed at lowering U.S. drug costs, revisiting an idea that was blocked in court during his first term.

By Rebecca Robbins and Margot Sanger-Katz

Clinical Trials CVS Caremark Corporation Drugs (Pharmaceuticals) Eli Lilly and Company GLP-1 RAs (Drug) Health Insurance and Managed Care Novo Nordisk A/S Obesity Prices (Fares, Fees and Rates) Research Weight

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.

By Rebecca Robbins and Reed Abelson

Bankruptcies Delaware Diet and Nutrition Drugs (Pharmaceuticals) New York City Weight Weight Watchers International Inc Winfrey, Oprah

WeightWatchers Files for Bankruptcy to Reduce $1 Billion in Debt

The company, which has shaped how millions eat and exercise, is trying to reduce its debt as it expands its telehealth business.

By John Yoon

Bureau of Economic Analysis China Customs (Tariff) Drugs (Pharmaceuticals) International Trade and World Market

Chinese Imports to US Hit 20-Year Low as Tariffs Sink In

While imports can swing with seasonal shifts, President Trump’s ratcheting up of U.S. tariffs on China has begun to cascade through supply chains, government data shows.

By Karl Russell and Ana Swanson